(Q51550263)
Statements
Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo (English)
Jianghong Jiang
Rana A K Singh
Weitao Song
Michael Barry
Mary H Huls
Kevin M Slawin
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference